Earnings call transcript: C3.ai Q4 2025 reports EPS beat, stock jumps

C3.ai (AI) reported Q4 2025 earnings that exceeded expectations, with a loss per share of -$0.16, beating estimates of -$0.20, and revenue reaching $108.7 million, slightly above forecasts, driving the stock up 10.17% in after-hours trading. The company highlighted a 26% year-over-year increase in total revenue and progress in generative AI applications and strategic partnerships, notably the renewal of the Baker Hughes partnership through 2028. C3.ai provided Q1 FY2026 revenue guidance between $100 million and $109 million and full-year guidance ranging from $447.5 million to $484.5 million, expecting non-GAAP profitability in the second half of FY2027 and free cash flow positivity by Q4 FY2026 amid geopolitical uncertainties.

Analysis

C3.ai Inc. reported a robust Q4 2025, exceeding analyst expectations with revenue of $108.7 million, a 26% year-over-year increase, and a narrower-than-anticipated loss per share of -$0.16. This performance, driven by strong growth in generative AI applications—now a ~$60 million annualized recurring revenue business—and significant progress in strategic partnerships, notably the renewal and expansion of its agreement with Baker Hughes through 2028 and deepening collaborations with Microsoft, AWS, and GCP, spurred a 10.17% surge in its stock price in after-hours trading. Notably, $33.8 million of Q4 revenue, approximately 31% of the total, came from demonstration licenses sold to partners and customers, an investment intended to fuel future adoption. The company achieved positive free cash flow of $10.3 million in the quarter and maintains a stable cash position of approximately $742.7 million, though InvestingPro assigns it a "Fair" overall financial health score of 1.9 out of 5. C3.ai's guidance for FY2026 projects revenue between $447.5 million and $484.5 million, with a non-GAAP operating loss of $65 million to $100 million, reflecting ongoing investments and a cautious outlook due to geopolitical uncertainties. Management reiterated its target for non-GAAP profitability in the second half of FY2027 and free cash flow positivity by Q4 FY2026, emphasizing its unique market position with turnkey enterprise AI solutions and a patent in Agentic AI. Despite the positive momentum, the stock's high beta of 1.98 indicates significant volatility, and InvestingPro suggests it trades near its fair value, with analyst price targets ranging from $15 to $56.

Key Decisions for Investors

• Investors should acknowledge C3.ai's strong Q4 revenue growth and earnings beat, while remaining mindful of the stock's high volatility (beta 1.98) and the company's current "Fair" financial health rating from InvestingPro.
• Closely monitor the execution and ramp-up of strategic partnerships, particularly with Microsoft, AWS, and the renewed Baker Hughes agreement, as their success is integral to achieving guided growth and further revenue diversification, noting the 37% year-over-year growth in non-Baker Hughes Q4 revenue.
• Factor in the projected timeline for non-GAAP profitability by H2 FY2027 and consistent free cash flow positivity from Q4 FY2026, considering near-term margin compression from strategic investments, the significant contribution of demonstration license sales to current revenue, and the wider FY2026 guidance range which reflects market and geopolitical uncertainties.
• Assess the long-term growth potential stemming from C3.ai's positioning in enterprise AI and its Agentic AI patent against a valuation near InvestingPro's fair value estimate and a broad range of analyst price targets.